GSK shows early promise in ovarian and womb cancer drug trial

A diverse group of medical professionals and researchers attentively listens to a presentation about GSK's promising early trial results for a new cancer drug targeting ovarian and womb cancers during an investor conference.

The trial, which began in early 2023, involved a diverse group of participants across multiple sites. Preliminary data indicated that the drug demonstrated a significant reduction in tumor size for a substantial percentage of patients, suggesting its efficacy in combating these aggressive forms of cancer. For more details on how clinical trials work, visit this … Read more

Boy with rare condition amazes doctors after world-first gene therapy

Boy with rare condition amazes doctors after world-first gene therapy

Image – via Pixabay Understanding the background and importance of this condition The condition, known as X-Linked Myotubular Myopathy (XLMTM), affects skeletal muscles and is primarily seen in young boys. Muscle weakness and respiratory complications that often accompany this ailment can severely reduce the quality of life for those affected. The urgency for effective therapies … Read more